FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carlo Altamura

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
George Anderson; Karl Bechter; Michael Berk; Peter Buckley; U N Das; Monojit Debnath; Bernardo Dell'osso; Seetal Dodd; S Hossein Fatemi; Shigenobu Kanba; Buranee Kanchanatawan; Urs Meyer; Akira Monji; Norbert Müller; A Carlo Altamura; Michael Maes
Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia.
A Carlo Altamura; Alessio Fiorentini; Sara Pozzoli; Bernardo Dell'Osso
Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology.
Bernardo Dell'Osso; Lucio Oldani; M Carlotta Palazzo; Ilaria Balossi; Mariateresa Ciabatti; A Carlo Altamura
Vagus nerve stimulation in treatment-resistant depression: acute and follow-up results of an italian case series.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carlo Altamura (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: George Anderson; Karl Bechter; Michael Berk; Peter Buckley; U N Das; Monojit Debnath; Bernardo Dell'osso; Seetal Dodd; S Hossein Fatemi; Shigenobu Kanba; Buranee Kanchanatawan; Urs Meyer; Akira Monji; Norbert Müller; A Carlo Altamura; Michael Maes
Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2013;42():1-4.
2013: A Carlo Altamura; Alessio Fiorentini; Sara Pozzoli; Bernardo Dell'Osso
Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology.
Progress in neuro-psychopharmacology & biological psychiatry 2013;42():63-70.
2013: Bernardo Dell'Osso; Lucio Oldani; M Carlotta Palazzo; Ilaria Balossi; Mariateresa Ciabatti; A Carlo Altamura
Vagus nerve stimulation in treatment-resistant depression: acute and follow-up results of an italian case series.
The journal of ECT 2013;29(1):41-4.
2013: Claudio D'Addario; Bernardo Dell'Osso; Andrea Di Francesco; Daniela Galimberti; A Carlo Altamura; Beatrice Benatti; Maria Carlotta Palazzo; Elio Scarpini; Mauro Maccarrone
Epigenetic modulation of BDNF gene in patients with major depressive disorder.
Biological psychiatry 2013;73(2):e6-7.
2013: Bernardo Dell'Osso; Cristina Dobrea; Chiara Arici; Beatrice Benatti; Giulia Camuri; A Carlo Altamura
Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study.
Neuropsychiatric disease and treatment 2013;9():205-9.
2013: Bernardo Dell'Osso; M Carlotta Palazzo; Gianmaria Prati; Maria Grazia Rumi; Alessio Aghemo; Flaminia Cavallaro; Massimo Colombo; A Carlo Altamura
Predictors of psychopathological outcome during peg-interferon and ribavirin therapy in patients with chronic HCV-correlated hepatitis.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2013;33(1):9-14.
2013: Bernardo Dell'Osso; Ira D Glick; David S Baldwin; A Carlo Altamura
Can long-term outcomes be improved by shortening the duration of untreated illness in psychiatric disorders? A conceptual framework.
Psychopathology 2013;46(1):14-21.
2013: Bernardo Dell'Osso; Mauro Porta; Domenico Servello; A Carlo Altamura
Deep Brain Stimulation device removal after scar picking behaviors in a patient with treatment-resistant obsessive compulsive disorder.
Brain stimulation 2013;6(1):96-8.
2012: Bernardo Dell'Osso; Cristina Dobrea; Chiara Arici; Beatrice Benatti; A Carlo Altamura
Efficacy, tolerability, compliance, and quality of life of patients with mood disorders switched from quetiapine immediate release to extended release.
International clinical psychopharmacology 2012;27(6):310-3.
2012: Claudio D'Addario; Bernardo Dell'Osso; Manuela Di Benedetto; Andrea Di Francesco; Chiara Fenoglio; Daniela Galimberti; Licia Lietti; Mauro Maccarrone; Daniela Mari; Maria Carlotta Palazzo; Patrizia Romualdi; Elio Scarpini; Beatrice Arosio; Beatrice Benatti; Luigi Bergamaschini; Nereo Bresolin; Sanzio Candeletti; Elisabetta Cattaneo; Francesca Cortini; A Carlo Altamura
Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2012;37(7):1647-55.
2012: A Carlo Altamura; Massimiliano Buoli; Bernardo Dell'Osso; Massimo Carlo Mauri; Donatella Moliterno; Silvia Paletta; Silvio R Bareggi
Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational study.
Clinical drug investigation 2012;32(3):213-9.
2012: Bernardo Dell'Osso; Cristina Dobrea; Marta Serati; Massimiliano Buoli; Giulia Camuri; A Carlo Altamura
Duloxetine in affective disorders: a naturalistic study on psychiatric and medical comorbidity, use in association and tolerability across different age groups.
Clinical practice and epidemiology in mental health : CP & EMH 2012;8():120-5.
2012: Claudio D'Addario; Bernardo Dell'Osso; Andrea Di Francesco; Daniela Galimberti; Cristina Gussago; A Carlo Altamura; Beatrice Arosio; Monica Bari; Daniela Mari; Elio Scarpini; Mauro Maccarrone
Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.
PloS one 2012;7(6):e39186.
2011: Ira D Glick; Stefan Leucht; Stephen R Marder; Peter Weiden; A Carlo Altamura; Christoph Correll; John G Csernansky; John M Davis
Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach.
The Journal of clinical psychiatry 2011;72(12):1616-27.
2011: Bernardo Dell'Osso; Lucio Oldani; M Carlotta Palazzo; A Carlo Altamura
The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects.
CNS neuroscience & therapeutics 2011;17(6):723-32.
2011: A Carlo Altamura; Alessandra Albano; Massimiliano Buoli; Francesca Colombo; Bernardo Dell'Osso; Sara Pozzoli; Marta Serati; Jules Angst
The impact of brief depressive episodes on the outcome of bipolar disorder and major depressive disorder: a 1-year prospective study.
Journal of affective disorders 2011;134(1-3):133-7.
2011: A Carlo Altamura; Ira D Glick; Riccardo A Paoli; Marta Serati; Alessandra Albano; Bernardo Dell'Osso
An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.
European archives of psychiatry and clinical neuroscience 2011;261(7):489-508.
2011: A Carlo Altamura; Massimiliano Buoli; Marta Serati; Bernardo Dell'Osso
Augmentative quetiapine in partial/nonresponders with generalized anxiety disorder: a randomized, placebo-controlled study.
International clinical psychopharmacology 2011;26(4):201-5.
2011: Bernardo Dell'Osso; Alberto Priori; A Carlo Altamura
Efficacy and safety of transcranial direct current stimulation in major depression.
Biological psychiatry 2011;69(8):e23-4.
2011: A Carlo Altamura; Matteo Porcellana; Paola M Marinaccio; Maria Ciabatti; Emanuela P Nocito; Lorenzo Magri; Cinzia Bressi
Is it possible to assess subjective well-being among bipolar inpatients? An 18-week follow-up study.
General hospital psychiatry 2011;33(2):185-90.
2011: Bernardo Dell'Osso; Vittoria Vecchi; Matteo Benedetti; Sara Bortolussi; Giulia Camuri; Filippo Castellano; A Carlo Altamura
Meta-Review of Metanalytic Studies with Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Major Depression.
Clinical practice and epidemiology in mental health : CP & EMH 2011;7():167-77.
2011: A Carlo Altamura; Licia Lietti; Cristina Dobrea; Beatrice Benatti; Chiara Arici; Bernardo Dell'Osso
Mood stabilizers for patients with bipolar disorder: the state of the art.
Expert review of neurotherapeutics 2011;11(1):85-99.
2010: A Carlo Altamura; Guy M Goodwin
How Law 180 in Italy has reshaped psychiatry after 30 years: past attitudes, current trends and unmet needs.
The British journal of psychiatry : the journal of mental science 2010;197(4):261-2.
2010: A Carlo Altamura; Ira D Glick
Designing outcome studies to determine efficacy and safety of antipsychotics for 'real world' treatment of schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2010;13(7):971-3.
2010: A Carlo Altamura; Bernardo Dell'Osso; Heather A Berlin; Massimiliano Buoli; Roberta Bassetti; Emanuela Mundo
Duration of untreated illness and suicide in bipolar disorder: a naturalistic study.
European archives of psychiatry and clinical neuroscience 2010;260(5):385-91.
2010: Bernardo Dell'Osso; M Buoli; Eric Hollander; A Carlo Altamura
Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(1):59-65.
2010: Bernardo Dell'Osso; Massimiliano Buoli; David S Baldwin; A Carlo Altamura
Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy.
Human psychopharmacology 2010;25(1):17-29.
2010: A Carlo Altamura; Emanuela Mundo; Elisabetta Cattaneo; Sara Pozzoli; Bernardo Dell'osso; Massimo Gennarelli; Carlo Vergani; Daria Trabattoni; Beatrice Arosio; Mario Clerici
The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study.
Neuroimmunomodulation 2010;17(2):126-31.
2009: A Carlo Altamura
Law 180 after 30 years - reflections on unmet needs and risks of loss of identity for Italian psychiatrists.
Acta psychiatrica Scandinavica 2009;120(6):501-2.
2009: Mario Clerici; Beatrice Arosio; Emanuela Mundo; Elisabetta Cattaneo; Sara Pozzoli; Bernardo Dell'Osso; Carlo Vergani; Daria Trabattoni; A Carlo Altamura
Cytokine polymorphisms in the pathophysiology of mood disorders.
CNS spectrums 2009;14(8):419-25.
2009: Cinzia Bressi; Matteo Porcellana; Orsola Gambini; Luca Madia; Riccardo Muffatti; Alberto Peirone; Susanna Zanini; Arcadio Erlicher; Silvio Scarone; A Carlo Altamura
Burnout among psychiatrists in Milan: a multicenter survey.
Psychiatric services (Washington, D.C.) 2009;60(7):985-8.
2009: Bernardo Dell'Osso; Massimiliano Buoli; Riccardo Riundi; Nazario D'Urso; Sara Pozzoli; Roberta Bassetti; Emanuela Mundo; A Carlo Altamura
Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset.
Neuropsychiatric disease and treatment 2009;5():399-404.
2009: Bernardo Dell'Osso; A Carlo Altamura
Augmentative transcranial magnetic stimulation (TMS) combined with brain navigation in drug-resistant rapid cycling bipolar depression: a case report of acute and maintenance efficacy.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 2):673-6.
2008: A Carlo Altamura; Emanuela Mundo; Bernardo Dell'Osso; G Tacchini; M Buoli; Joseph Calabrese
Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
Journal of affective disorders 2008;110(1-2):135-41.
2008: A Carlo Altamura; Bernardo Dell'Osso; Massimiliano Buoli; Silvia Zanoni; Emanuela Mundo
Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: a short-term, low dose, randomized, placebo-controlled study.
Journal of clinical psychopharmacology 2008;28(4):406-10.
2008: A Carlo Altamura; D Armadoros; M Jaeger; R Kernish; J Locklear; H-P Volz
Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective.
Current medical research and opinion 2008;24(8):2271-82.
2008: A Carlo Altamura; Bernardo Dell'Osso; Massimiliano Buoli; Monica Francesca Bosi; Emanuela Mundo
Short-term intravenous citalopram augmentation in partial/nonresponders with major depression: a randomized placebo-controlled study.
International clinical psychopharmacology 2008;23(4):198-202.
2008: A Carlo Altamura; Bernardo Dell'Osso; Nazario D'Urso; Michela Russo; Sara Fumagalli; Emanuela Mundo
Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorder.
CNS spectrums 2008;13(5):415-22.
2008: Maura Pugliatti; Patrik Sobocki; Ettore Beghi; Stefano Pini; Giovanni B Cassano; A Carlo Altamura; Sara Pozzoli; Giulio Rosati
Cost of disorders of the brain in Italy.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2008;29(2):99-107.
2008: Bernardo Dell'Osso; Andrea Allen; A Carlo Altamura; Massimiliano Buoli; Eric Hollander
Impulsive-compulsive buying disorder: clinical overview.
The Australian and New Zealand journal of psychiatry 2008;42(4):259-66.
2008: A Carlo Altamura; Bernardo Dell'Osso; Serena Vismara; Emanuela Mundo
May duration of untreated illness influence the long-term course of major depressive disorder?
European psychiatry : the journal of the Association of European Psychiatrists 2008;23(2):92-6.
2008: Bernardo Dell'Osso; Emanuela Mundo; Donatella Marazziti; A Carlo Altamura
Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series.
Journal of psychopharmacology (Oxford, England) 2008;22(2):210-3.
2008: A Carlo Altamura; Jose M Goikolea
Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder.
Neuropsychiatric disease and treatment 2008;4(1):311-7.
2007: Silvio R Bareggi; Emanuela Mundo; Bernardo Dell'Osso; A Carlo Altamura
The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.
Expert opinion on drug metabolism & toxicology 2007;3(5):741-53.
2007: A Carlo Altamura; Bernardo Dell'Osso; Emanuela Mundo; Liliana Dell'osso
Duration of untreated illness in major depressive disorder: a naturalistic study.
International journal of clinical practice 2007;61(10):1697-700.
2007: A Carlo Altamura; William V Bobo; Herbert Y Meltzer
Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.
International clinical psychopharmacology 2007;22(5):249-67.
2007: A Carlo Altamura
Bipolar spectrum and drug addiction.
Journal of affective disorders 2007;99(1-3):285.
2007: Philippe H Robert; E Michel; J Van Os; A Carlo Altamura; Julio Bobes; J Gerlach; Jonathan S E Hellewell; S Kasper; D Nabel
[2-COM: presentation of an instrument facilitating communication between physicians and carers in daily practice].
L'Encéphale 2007;33(1):60-4.
2007: Bernardo Dell'Osso; A Carlo Altamura; Emanuela Mundo; Donatella Marazziti; Eric Hollander
Diagnosis and treatment of obsessive-compulsive disorder and related disorders.
International journal of clinical practice 2007;61(1):98-104.
2007: A Carlo Altamura; Emanuela Mundo; Roberta Bassetti; A Green; Jean-Pierre Lindenmayer; Larry Alphs; Herbert Y Meltzer
Transcultural differences in suicide attempters: analysis on a high-risk population of patients with schizophrenia or schizoaffective disorder.
Schizophrenia research 2007;89(1-3):140-6.
2006: Bernardo Dell'Osso; A Carlo Altamura; Andrea Allen; Donatella Marazziti; Eric Hollander
Epidemiologic and clinical updates on impulse control disorders: a critical review.
European archives of psychiatry and clinical neuroscience 2006;256(8):464-75.
2006: A Carlo Altamura; Annalisa Santini; Emanuela Mundo
Treatment issues in bipolar II depression.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(6):775-6.
2006: Bernardo Dell'Osso; Emanuela Mundo; A Carlo Altamura
Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a six-month follow-up case series.
CNS spectrums 2006;11(11):879-83; quiz 885.
2006: Emanuela Mundo; Elisabetta Cattaneo; Silvia Zanoni; A Carlo Altamura
The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder.
Neuropsychiatric disease and treatment 2006;2(2):139-48.
2006: Emanuela Mundo; Elisabetta Cattaneo; Michela Russo; A Carlo Altamura
Clinical variables related to antidepressant-induced mania in bipolar disorder.
Journal of affective disorders 2006;92(2-3):227-30.
2005: A Carlo Altamura; Annalisa Santini; Daniele Salvadori; Emanuela Mundo
Duration of untreated illness in panic disorder: a poor outcome risk factor?
Neuropsychiatric disease and treatment 2005;1(4):345-7.
2005: Bernardo Dell'Osso; A Carlo Altamura; Andrea Allen; Eric Hollander
Brain stimulation techniques in the treatment of obsessive-compulsive disorder: current and future directions.
CNS spectrums 2005;10(12):966-79, 983.
2005: A Carlo Altamura
[The methodology of the studies in the treatment of maniac admissions].
L'Encéphale 2005;31(Pt 2):S42-3.
2005: Emanuela Mundo; A Carlo Altamura; Serena Vismara; Roberta Zanardini; Stefano Bignotti; Roberto Randazzo; Claudio Montresor; Massimo Gennarelli
MCP-1 gene (SCYA2) and schizophrenia: a case-control association study.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2005;132B(1):1-4.
2005: A Carlo Altamura; Roberta Bassetti; Elisabetta Cattaneo; Serena Vismara
Some biological correlates of drug resistance in schizophrenia: a multidimensional approach.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6 Suppl 2():23-30.
2004: A Carlo Altamura; Claudio Montresor; Daniele Salvadori; Emanuela Mundo
Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2004;7(4):481-7.
2004: A Carlo Altamura; Michela Russo; Serena Vismara; Emanuela Mundo
Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder.
Journal of clinical psychopharmacology 2004;24(4):454-6.
2004: A Carlo Altamura; Roberta Bassetti; Annalisa Santini; Giovanni B Frisoni; Emanuela Mundo
Emotional withdrawal, CT abnormalities and drug response in late life depression.
Progress in neuro-psychopharmacology & biological psychiatry 2004;28(2):349-54.
2004: Jim van Os; A Carlo Altamura; Julio Bobes; Jes Gerlach; Jonathan S E Hellewell; Siegfried Kasper; Dieter Naber; Philippe Robert
Evaluation of the Two-Way Communication Checklist as a clinical intervention. Results of a multinational, randomised controlled trial.
The British journal of psychiatry : the journal of mental science 2004;184():79-83.
2003: A Carlo Altamura; Daniele Salvadori; Donato Madaro; Annalisa Santini; Emanuela Mundo
Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study.
Journal of affective disorders 2003;76(1-3):267-71.
2003: A Carlo Altamura; Roberta Bassetti; Luisella Bocchio; Annalisa Santini; Emanuela Mundo
Season of birth and inflammatory response system in schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2003;27(5):879-80.
2003: Mauro Giovanni Carta; A Carlo Altamura; maria carolina hardoy; Federica Pinna; Stefania Medda; Liliana Dell'osso; Bernardo Carpiniello; Jules Angst
Is recurrent brief depression an expression of mood spectrum disorders in young people? Results of a large community sample.
European archives of psychiatry and clinical neuroscience 2003;253(3):149-53.
2003: A Carlo Altamura; Roberta Bassetti; Stefano Bignotti; Rosaria Pioli; Emanuela Mundo
Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study.
Schizophrenia research 2003;60(1):47-55.
2003: A Carlo Altamura; Francesca Sassella; Annalisa Santini; Claudio Montresor; Sara Fumagalli; Emanuela Mundo
Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.
Drugs 2003;63(5):493-512.
2003: Herbert Y Meltzer; Larry Alphs; Alan I Green; A Carlo Altamura; Ravi Anand; Alberto Bertoldi; Marc Bourgeois; Guy Chouinard; M Zahur Islam; John M Kane; Ranga Krishnan; Jean-Pierre Lindenmayer; Steven G Potkin
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
Archives of general psychiatry 2003;60(1):82-91.
2002: Jim van Os; A Carlo Altamura; Julio Bobes; D C Owens; J Gerlach; Jonathan S E Hellewell; S Kasper; D Naber; Nicholas Tarrier; P Robert
2-COM: an instrument to facilitate patient-professional communication in routine clinical practice.
Acta psychiatrica Scandinavica 2002;106(6):446-52.
2002: Bernardo Carpiniello; Antonella Baita; Mauro Giovanni Carta; Rossella Sitzia; Adolfo Maria Macciardi; Sergio Murgia; A Carlo Altamura
Clinical and psychosocial outcome of patients affected by panic disorder with or without agoraphobia: results from a naturalistic follow-up study.
European psychiatry : the journal of the Association of European Psychiatrists 2002;17(7):394-8.
2001: A Carlo Altamura; Roberta Bassetti; F Sassella; Daniele Salvadori; Emanuela Mundo
Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study.
Schizophrenia research 2001;52(1-2):29-36.
2000: A Carlo Altamura; Silvio R Bareggi
Comment on 'reduced haloperidol does not interfere with antipsychotic activity of halperidol in the treatment of acute schizophrenia'.
International clinical psychopharmacology 2000;15(5):303-4.
1999: A Carlo Altamura; Francesco Boin; M Maes
HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1999;10(1):1-4.
1999: A Carlo Altamura; Rosaria Pioli; M Vitto; P Mannu
Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders.
International clinical psychopharmacology 1999;14(4):239-45.
1998: A Carlo Altamura; Stefano Bignotti; Gian Battista Tura; Rita Curreli; Rosaria Pioli
Depressive symptomatology during clozapine treatment: two case reports.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1998;8(3):239-40.
1998: John M Kane; E Aguglia; A Carlo Altamura; J L Ayuso Gutierrez; Nicoletta Brunello; W W Fleischhacker; W Gaebel; J Gerlach; J D Guelfi; W Kissling; Y D Lapierre; E Lindström; Julien Mendlewicz; Giorgio Racagni; Luis Salvador-Carulla; N R Schooler
Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1998;8(1):55-66.
1998: A Carlo Altamura; Mauro Giovanni Carta; G Tacchini; A Musazzi; M R Pioli
Prevalence of somatoform disorders in a psychiatric population: an Italian nationwide survey. Italian Collaborative Group on Somatoform Disorders.
European archives of psychiatry and clinical neuroscience 1998;248(6):267-71.
1996: A Carlo Altamura
Novel antipsychotics and the problem of clinical stabilization in schizophrenia: are they "stabilizer" rather than typical compounds?
International clinical psychopharmacology 1996;11(3):153-5.
1995: A Carlo Altamura; Mauro Giovanni Carta; Bernardo Carpiniello; A Piras; M V Macciò; L Marcia
Lifetime prevalence of brief recurrent depression (results from a community survey).
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5 Suppl():99-102.
1995: A Carlo Altamura; G L Tacchini; Michael Maes
Haloperidol plasma 'threshold' levels for relapse prevention in schizophrenia: a study with haloperidol decanoate.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5 Suppl():55-8.
1994: G Tacchini; M T Coppola; A Musazzi; A Carlo Altamura; Giordano Invernizzi
[Multinational validation of the Composite International Diagnostic Interview (CIDI)].
Minerva psichiatrica 1994;35(2):63-80.
1994: A Carlo Altamura; A R Moro; Mauro Percudani
Clinical pharmacokinetics of fluoxetine.
Clinical pharmacokinetics 1994;26(3):201-14.
1994: Massimo Carlo Mauri; Antonio Vita; G M Giobbio; A Ferrara; M Dieci; A Bitetto; A Carlo Altamura
Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables.
International clinical psychopharmacology 1994;9(1):3-7.
1993: A Carlo Altamura; Mauro Percudani
The use of antidepressants for long-term treatment of recurrent depression: rationale, current methodologies, and future directions.
The Journal of clinical psychiatry 1993;54 Suppl():29-37; discussion 38.
1993: A Carlo Altamura
A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance.
Schizophrenia research 1993;8(3):187-98.
1993: Massimo Carlo Mauri; S Gianetti; L Pugnetti; A Carlo Altamura
Quazepam versus triazolam in patients with sleep disorders: a double-blind study.
International journal of clinical pharmacology research 1993;13(3):173-7.
1992: A Carlo Altamura
Relevance of pharmacokinetic studies on antipsychotics in the management of schizophrenic disorders.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():243A-244A.
1991: A Carlo Altamura; Massimo Carlo Mauri; G Regazzetti; M T Coppola
[L-sulpiride in the treatment of somatoform disturbances: a double-blind study with racemic sulpiride].
Minerva psichiatrica 1991;32(1):25-9.
1990: A Carlo Altamura; M G Regazzetti; M Porta
Nimodipine in human alcohol withdrawal syndrome--an open study.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1990;1(1):37-40.
1990: Raffaele Canger; A Carlo Altamura; O Belvedere; F Monaco; G C Monza; G C Muscas; R Mutani; B Panetta; F Pisani; Gaetano Zaccara
Conventional vs controlled-release carbamazepine: a multicentre, double-blind, cross-over study.
Acta neurologica Scandinavica 1990;82(1):9-13.
1990: Silvio R Bareggi; R Cavallaro; Rodolfo Pirola; A Carlo Altamura
Pharmacokinetics and adverse effects of single doses of dothiepin in young and elderly subjects.
Progress in neuro-psychopharmacology & biological psychiatry 1990;14(2):163-70.
1990: Massimo Carlo Mauri; Mauro Percudani; M G Regazzetti; A Carlo Altamura
Alternative prophylactic treatments to lithium in bipolar disorders.
Clinical neuropharmacology 1990;13 Suppl 1():S90-6.
1990: A Carlo Altamura; Massimo Carlo Mauri; T Girardi; B Panetta
Alcoholism and depression: a placebo controlled study with viloxazine.
International journal of clinical pharmacology research 1990;10(5):293-8.
1990: A Carlo Altamura; Massimo Carlo Mauri; T Girardi; B Panetta
Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia.
International journal of clinical pharmacology research 1990;10(4):223-8.
1990: A Carlo Altamura; R Cavallaro; M G Regazzetti
Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics.
European archives of psychiatry and clinical neuroscience 1990;240(1):9-12.
1990: A Carlo Altamura
Drug-resistance phenomena in major psychoses: their discrimination and causal mechanisms.
Clinical neuropharmacology 1990;13 Suppl 1():S1-15.
1989: A Carlo Altamura; Massimo Carlo Mauri; F De Novellis; Mauro Percudani; V Vampini
Residual neuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrine.
Pharmacopsychiatry 1989;22(6):246-9.
1989: A Carlo Altamura; F Colacurcio; Massimo Carlo Mauri; M De Vanna; R Rigamonti; M Maj; F Veltro; Paolo Pancheri; R Delle Chiaie; M Porta
[Controlled clinical study on the effect of quazepam versus triazolam in patients with sleep disorders].
Minerva psichiatrica 1989;30(3):159-64.
1989: A Carlo Altamura; Mauro Percudani; G Guercetti; Giordano Invernizzi
Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptiline.
International clinical psychopharmacology 1989;4 Suppl 1():103-6.
1989: A Carlo Altamura; F De Novellis; G Guercetti; Giordano Invernizzi; Mauro Percudani; S A Montgomery
Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial.
International journal of clinical pharmacology research 1989;9(6):391-6.
1989: A Carlo Altamura; Massimo Carlo Mauri; N Rudas; Bernardo Carpiniello; R Montanini; M Perini; P L Scapicchio; C Hadjchristos; G Carucci; M Minervini
Clinical activity and tolerability of trazodone, mianserin, and amitriptyline in elderly subjects with major depression: a controlled multicenter trial.
Clinical neuropharmacology 1989;12 Suppl 1():S25-33; S34-7.
1989: A Carlo Altamura; Massimo Carlo Mauri; R Cavallaro; M G Regazzetti; Silvio R Bareggi
Hydroxyhaloperidol and clinical outcome in schizophrenia.
Psychopharmacology series 1989;7():263-8.
1989: A Carlo Altamura; F Colacurcio; S Marini
Ritanserin versus lorazepam: a double-blind, cross-over study of reaction times in healthy volunteers.
International journal of clinical pharmacology research 1989;9(3):197-201.
1988: A Carlo Altamura; Massimo Carlo Mauri; F Colacurcio; P L Scapicchio; C Hadjchristos; G Carucci; M Minervini; R Montanini; M Perini; N Rudas
Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserin.
Psychopharmacology 1988;95 Suppl():S34-6.
1987: A Carlo Altamura; Massimo Carlo Mauri; M Mantero; M Brunetti
Clonazepam/haloperidol combination therapy in schizophrenia: a double blind study.
Acta psychiatrica Scandinavica 1987;76(6):702-6.
1987: A Carlo Altamura; F De Novellis; Massimo Carlo Mauri; R Gomeni
Plasma and brain pharmacokinetics of mianserin after single and multiple dosing in mice.
Progress in neuro-psychopharmacology & biological psychiatry 1987;11(1):23-33.
1987: A Carlo Altamura; Massimo Carlo Mauri; G Guercetti; Carlo Lorenzo Cazzullo
Fluphenazine decanoate in acute and maintenance therapy of schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 1987;11(5):613-23.
1986: A Carlo Altamura; Silvio R Bareggi; G Invernizzi; A Morganti; A Zanchetti
The effects of mianserin therapy on plasma renin activity in depressed patients.
Biological psychiatry 1986;21(13):1331-4.
1986: A Carlo Altamura; Massimo Carlo Mauri; G Guercetti
Prophylactic treatment with mianserin, therapy adherence and plasma monitoring. A case report.
Acta psychiatrica Scandinavica 1986;74(2):220-1.
1986: A Carlo Altamura; M Buccio; F Colacurcio; G Colombo; A Terzi
Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol.
Acta neurologica 1986;8(1):19-26.
1986: A Carlo Altamura; Massimo Carlo Mauri; G Guercetti
Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.
Progress in neuro-psychopharmacology & biological psychiatry 1986;10(1):67-75.
1986: A Carlo Altamura; M Buccio; G Colombo; A Terzi; C L Cazzullo
Combination therapy with haloperidol and orphenadrine in schizophrenia. A clinical and pharmacokinetic study.
L'Encéphale 1986;12(1):31-6.
1983: A Carlo Altamura; T Melorio
Mianserin metabolites.
British journal of clinical pharmacology 1983;16(2):201-3.
1983: C M Cornaggia; A Carlo Altamura; M Bianchi; Raffaele Canger; P Polana; C Pruneri
PB:PRM ratio in patients with epilepsy treated with primidone.
International journal of clinical pharmacology research 1983;3(3):185-93.
1983: A Carlo Altamura; T Melorio; G Invernizzi; F Colacurcio; R Gomeni
Age-related differences in kinetics and side-effects of viloxazine in man and their clinical implications.
Psychopharmacology 1983;81(4):281-5.
1982: A Carlo Altamura; Silvio R Bareggi; C M Cornaggia; G Grieco; G Invernizzi; T Melorio; L Zecca
Long-term treatment with mianserin: a clinical study with plasma levels.
Advances in biochemical psychopharmacology 1982;32():357-61.
1982: A Carlo Altamura; T Melorio; G Invernizzi; R Gomeni
Influence of age on mianserin pharmacokinetics.
Psychopharmacology 1982;78(4):380-2.
1981: C L Cazzullo; A Carlo Altamura; C M Cornaggia; Raffaele Canger; C Pruneri
Therapeutic plasma levels of some anticonvulsants in focal epilepsy in relation to computerized axial tomography.
L'Encéphale 1981;7(2):191-7.